HYPERION DEFI INC (HYPD) Stock Fundamental Analysis

NASDAQ:HYPD • US30234E2037

2.83 USD
-0.29 (-9.29%)
Last: Feb 27, 2026, 02:43 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HYPD. HYPD was compared to 192 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of HYPD have multiple concerns. HYPD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year HYPD has reported negative net income.
  • In the past year HYPD has reported a negative cash flow from operations.
  • HYPD had negative earnings in each of the past 5 years.
  • HYPD had a negative operating cash flow in each of the past 5 years.
HYPD Yearly Net Income VS EBIT VS OCF VS FCFHYPD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -60.17%, HYPD is doing worse than 65.10% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -70.41%, HYPD is in line with its industry, outperforming 44.27% of the companies in the same industry.
Industry RankSector Rank
ROA -60.17%
ROE -70.41%
ROIC N/A
ROA(3y)-514.41%
ROA(5y)-328.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HYPD Yearly ROA, ROE, ROICHYPD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • HYPD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HYPD Yearly Profit, Operating, Gross MarginsHYPD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K -600K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • HYPD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, HYPD has more shares outstanding
  • Compared to 5 years ago, HYPD has more shares outstanding
  • Compared to 1 year ago, HYPD has a worse debt to assets ratio.
HYPD Yearly Shares OutstandingHYPD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
HYPD Yearly Total Debt VS Total AssetsHYPD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • HYPD has an Altman-Z score of -3.50. This is a bad value and indicates that HYPD is not financially healthy and even has some risk of bankruptcy.
  • HYPD's Altman-Z score of -3.50 is in line compared to the rest of the industry. HYPD outperforms 41.67% of its industry peers.
  • HYPD has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.11, HYPD is in line with its industry, outperforming 51.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -3.5
ROIC/WACCN/A
WACC10.94%
HYPD Yearly LT Debt VS Equity VS FCFHYPD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

2.3 Liquidity

  • A Current Ratio of 2.25 indicates that HYPD has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.25, HYPD is in line with its industry, outperforming 42.71% of the companies in the same industry.
  • A Quick Ratio of 2.25 indicates that HYPD has no problem at all paying its short term obligations.
  • HYPD's Quick ratio of 2.25 is in line compared to the rest of the industry. HYPD outperforms 48.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 2.25
HYPD Yearly Current Assets VS Current LiabilitesHYPD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • HYPD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.98%.
  • The Revenue has grown by 1407.89% in the past year. This is a very strong growth!
  • The Revenue for HYPD have been decreasing by -84.00% on average. This is quite bad
EPS 1Y (TTM)4.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.22%
Revenue 1Y (TTM)1407.89%
Revenue growth 3Y-84%
Revenue growth 5YN/A
Sales Q2Q%18806.25%

3.2 Future

  • Based on estimates for the next years, HYPD will show a very strong growth in Earnings Per Share. The EPS will grow by 26.80% on average per year.
  • Based on estimates for the next years, HYPD will show a very strong growth in Revenue. The Revenue will grow by 98.76% on average per year.
EPS Next Y82.74%
EPS Next 2Y43.59%
EPS Next 3Y26.8%
EPS Next 5YN/A
Revenue Next Year-7.67%
Revenue Next 2Y87.93%
Revenue Next 3Y98.76%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HYPD Yearly Revenue VS EstimatesHYPD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
HYPD Yearly EPS VS EstimatesHYPD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HYPD. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 0.90, the valuation of HYPD can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, HYPD is valued cheaply inside the industry as 99.48% of the companies are valued more expensively.
  • HYPD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.13.
Industry RankSector Rank
PE N/A
Fwd PE 0.9
HYPD Price Earnings VS Forward Price EarningsHYPD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HYPD Per share dataHYPD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40 -50

4.3 Compensation for Growth

  • HYPD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HYPD's earnings are expected to grow with 26.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.59%
EPS Next 3Y26.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HYPD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HYPERION DEFI INC

NASDAQ:HYPD (2/27/2026, 2:43:57 PM)

2.83

-0.29 (-9.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-13
Earnings (Next)04-13
Inst Owners9%
Inst Owner ChangeN/A
Ins Owners26.18%
Ins Owner Change22.84%
Market Cap23.97M
Revenue(TTM)57.30K
Net Income(TTM)-49.82M
Analysts82.5
Price Target5.99 (111.66%)
Short Float %33.55%
Short Ratio5.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)27.81%
EPS NY rev (1m)0%
EPS NY rev (3m)74.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-62.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-81.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.9
P/S 418.33
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-50.93
EYN/A
EPS(NY)3.14
Fwd EY111.01%
FCF(TTM)-9.74
FCFYN/A
OCF(TTM)-1.99
OCFYN/A
SpS0.01
BVpS8.35
TBVpS-0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -60.17%
ROE -70.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-514.41%
ROA(5y)-328.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5816.13%
Cap/Sales 114546%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 2.25
Altman-Z -3.5
F-Score4
WACC10.94%
ROIC/WACCN/A
Cap/Depr(3y)219.51%
Cap/Depr(5y)330.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.22%
EPS Next Y82.74%
EPS Next 2Y43.59%
EPS Next 3Y26.8%
EPS Next 5YN/A
Revenue 1Y (TTM)1407.89%
Revenue growth 3Y-84%
Revenue growth 5YN/A
Sales Q2Q%18806.25%
Revenue Next Year-7.67%
Revenue Next 2Y87.93%
Revenue Next 3Y98.76%
Revenue Next 5YN/A
EBIT growth 1Y-47.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-88.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-218%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.6%
OCF growth 3YN/A
OCF growth 5YN/A

HYPERION DEFI INC / HYPD FAQ

What is the fundamental rating for HYPD stock?

ChartMill assigns a fundamental rating of 3 / 10 to HYPD.


Can you provide the valuation status for HYPERION DEFI INC?

ChartMill assigns a valuation rating of 4 / 10 to HYPERION DEFI INC (HYPD). This can be considered as Fairly Valued.


Can you provide the profitability details for HYPERION DEFI INC?

HYPERION DEFI INC (HYPD) has a profitability rating of 0 / 10.